Translator Disclaimer
Presentation + Paper
8 March 2016 Effect of interstitial low level laser therapy on tibial defect
Author Affiliations +
Abstract
Tibial defect is very common musculoskeletal disorder which makes patient painful and uncomfortable. Many studies about bone regeneration tried to figure out fast bone healing on early phase. It is already known that low level laser therapy (LLLT) is very convenient and good for beginning of bone disorder. However, light scattering and absorption obstruct musculoskeletal therapy which need optimal photon energy delivery. This study has used an interstitial laser probe (ILP) to overcome the limitations of light penetration depth and scattering. Animals (mouse, C57BL/6) were divided into three groups: laser treated test group 1 (660 nm; power 10 mW; total energy 5 J) and test group 2 (660 nm; power 20 mW; total energy 10 J); and untreated control group. All animals were taken surgical operation to make tibial defect on right crest of tibia. The test groups were treated every 48 hours with ILP. Bone volume and X-ray attenuation coefficient were measured on 0, 14th and 28th day with u-CT after treatment and were used to evaluate effect of LLLT. Results show that bone volume of test groups has been improved more than control group. X-ray attenuation coefficients of each groups have slightly different. The results suggest that LLLT combined with ILP may affect on early phase of bone regeneration and may be used in various musculoskeletal disease in deep tissue layer.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Sangyeob Lee, Myungjin Ha, Donghyun Hwang, Sungkon Yu, Seulki Jang, Jihoon Park, Edalat Radfar, Hansung Kim, and Byungjo Jung "Effect of interstitial low level laser therapy on tibial defect", Proc. SPIE 9695, Mechanisms of Photobiomodulation Therapy XI, 96950D (8 March 2016); https://doi.org/10.1117/12.2211371
PROCEEDINGS
4 PAGES + PRESENTATION

SHARE
Advertisement
Advertisement
Back to Top